Scientific Leadership in Computational Biology

Scientific Leadership

Dr. Shahid Ullah, PhD

Founder & CEO

Leading the Future of AI-Driven Drug Discovery

Dr. Shahid Ullah is the Founder and Chief Executive Officer of Apoptra Discovery Ltd, a UK biotechnology company developing AI-powered solutions for drug discovery, biomarker discovery, and translational biomedical research. With expertise spanning molecular biology, computational biology, cancer genomics, and artificial intelligence, he leads the company's vision of transforming complex biomedical data into actionable therapeutic insights.

Drawing on research experience and an extensive background in cancer genetics and multi-omics data analysis, Dr. Ullah combines machine learning, bioinformatics, and molecular modelling to accelerate target identification, biomarker discovery, and early-stage therapeutic development. His scientific approach bridges computational prediction with biological validation, enabling robust, evidence-based research that supports precision medicine.

Under his leadership, Apoptra Discovery is building next-generation AI platforms that integrate multi-omics data, computational biology, and interpretable machine learning to support pharmaceutical innovation, academic collaboration, and translational biomedical research. The company is committed to delivering scientifically rigorous, transparent, and clinically relevant solutions that help accelerate the discovery of safer and more effective therapies.

Dr. Ullah has authored multiple peer-reviewed scientific publications and continues to lead collaborative research initiatives at the intersection of artificial intelligence, computational biology, and precision medicine, advancing innovative technologies for the future of healthcare.

Building the Future of Discovery

We are building a multidisciplinary network of scientists, computational biologists, AI engineers, and clinical collaborators who share our vision of accelerating drug discovery through artificial intelligence and computational biology. As Apoptra Discovery grows, we welcome opportunities to collaborate with outstanding researchers, innovators, and strategic advisors.

Computational Biologist

Machine Learning Engineer

Scientific Advisor

Apply multi-omics analysis, bioinformatics, and systems biology to uncover novel therapeutic targets, biomarkers, and biological insights that support AI-driven drug discovery.

Develop interpretable machine learning models for target prioritisation, biomarker discovery, molecular prediction, and precision medicine applications.

Provide strategic scientific guidance, strengthen translational research programmes, and support collaborations with academia, healthcare organisations, and industry partners.

Partner with Apoptra Discovery

We invite collaborators to join our mission to accelerate drug discovery and biomarker identification.